Introduction Vaccines have revolutionized public health, preventing millions of deaths from diseases such as measles, polio, and influenza. Yet, in recent years, vaccine hesitancy—the reluctance or refusal to vaccinate despite availability has emerged as a major threat to global health. Pharmacists, with their frequent patient contact and trusted role in healthcare, are uniquely positioned to ...

1. Renewed Surge Across Asia’s Major Cities Over the past few months, a notable surge in COVID-19 cases has emerged across major Asian cities, particularly Hong Kong and Singapore. Despite the disease being classified as endemic in most parts of the world, the virus continues to display cyclical resurgences. This latest wave is attributed to ...

Introduction Chronic diseases such as diabetes, hypertension, asthma, arthritis, and cardiovascular disorders are among the leading causes of morbidity and mortality worldwide. Managing these long-term conditions requires continuous care, regular monitoring, patient education, and medication adherence. While doctors diagnose and prescribe treatment plans, it is often pharmacists who remain in close contact with patients throughout ...

  Introduction Over-the-counter (OTC) medications are drugs available without a prescription, designed to treat common, minor ailments such as headaches, colds, allergies, indigestion, and fever. They are widely accessible, affordable, and convenient for immediate symptom relief. However, this convenience can sometimes lead to misuse, overuse, or unsafe combinations. While many people assume that OTC drugs ...

Introduction Modern medicine has transformed countless lives, offering effective treatments for diseases once considered fatal. However, no drug is without risk. Even medications approved through rigorous clinical trials may cause adverse effects once introduced to larger, more diverse populations. This is where pharmacovigilance the science of monitoring, assessing, and preventing adverse effects of pharmaceutical productscomes ...

India’s Contract Development and Manufacturing Organisations (CDMOs) are rapidly gaining prominence on the global pharmaceutical stage, fuelled by an increasing push from global pharma companies to diversify their supply chains away from China. This transition, known as the “China plus one” strategy, has gained fresh urgency in the wake of geopolitical tensions, pandemic-induced disruptions, and ...